Back to results
US 2026/0097004 A1Published application
Pharmaceutical composition for treating mast cell-mediated inflammatory diseases
OwnerLei CHU, Ethan A. LERNER +2inventors
InventorsLei CHU, Ethan A. LERNER, Vemuri B. REDDY, Yuping RAN
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to use of Atovaquone for treating and preventing acute and chronic inflammatory diseases in a mammal. The acute and chronic inflammatory diseases comprise mast cell-mediated inflammatory diseases.
Claims9
A pharmaceutical composition for treating or preventing mast cell-mediated inflammatory diseases, wherein the pharmaceutical composition comprises an active ingredient Atovaquone.
Use of Atovaquone in a pharmaceutical composition for treating or preventing mast cell-mediated inflammatory diseases.
Dependencies are inferred from the claim text.